Eagle Pharmaceuticals, Inc. (EGRX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 569.81M |
| Enterprise value | 527.92M |
| Trailing P/E | 15.51 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.28 |
| Price/book (mrq) | 2.64 |
| Enterprise value/revenue | 2.14 |
| Enterprise value/EBITDA | 9.24 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.67 |
| 52-week change 3 | 3.37% |
| S&P500 52-week change 3 | -11.93% |
| 52-week high 3 | 58.25 |
| 52-week low 3 | 41.01 |
| 50-day moving average 3 | 44.92 |
| 200-day moving average 3 | 48.83 |
Share statistics
| Avg vol (3-month) 3 | 137.18k |
| Avg vol (10-day) 3 | 170.4k |
| Shares outstanding 5 | 13.21M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 11.11M |
| % held by insiders 1 | 12.54% |
| % held by institutions 1 | 90.21% |
| Shares short (14 June 2022) 4 | 1.11M |
| Short ratio (14 June 2022) 4 | 8.01 |
| Short % of float (14 June 2022) 4 | 16.65% |
| Short % of shares outstanding (14 June 2022) 4 | 8.71% |
| Shares short (prior month 12 May 2022) 4 | 906.78k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | 14.56% |
| Operating margin (ttm) | 26.96% |
Management effectiveness
| Return on assets (ttm) | 14.30% |
| Return on equity (ttm) | 17.62% |
Income statement
| Revenue (ttm) | 246.17M |
| Revenue per share (ttm) | 18.99 |
| Quarterly revenue growth (yoy) | 180.90% |
| Gross profit (ttm) | 129.37M |
| EBITDA | 70.14M |
| Net income avi to common (ttm) | 35.85M |
| Diluted EPS (ttm) | 3.01 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 69.52M |
| Total cash per share (mrq) | 5.47 |
| Total debt (mrq) | 27.62M |
| Total debt/equity (mrq) | 12.79 |
| Current ratio (mrq) | 2.36 |
| Book value per share (mrq) | 17.01 |
Cash flow statement
| Operating cash flow (ttm) | 1.13M |
| Levered free cash flow (ttm) | -5.07M |
© 2022 Yahoo. All rights reserved.
